Evolving Regulatory Positions and Legacy Data Challenges: A Case Study of Fludioxonil’s Unknown Metabolite Fraction MF2 in European Active Ingredient Renewal. AJEER 2025, 1 (1), 1-7. https://doi.org/10.70844/ajeer.2025.1.7.